Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis

Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis ntaylor Thu, 09/12/2024 - 04:55